Siga Technologies (SIGA) Consolidated Net Income (2010 - 2025)
Siga Technologies' (SIGA) quarterly Consolidated Net Income came in at -$6.4 million in Q3 2025, down 573.67% YoY from $1.3 million in Q3 2024, and down 117.95% on a QoQ basis from $35.5 million in Q2 2025.
Siga Technologies (SIGA) Consolidated Net Income (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Consolidated Net Income data on file, last reported at -$6.4 million in Q3 2025.
- Quarterly Consolidated Net Income fell 573.67% year-over-year to -$6.4 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $28.7 million (down 51.44% YoY) and the FY2024 annual result came in at $59.2 million, down 6.41% from the prior year.
- Consolidated Net Income eased to -$6.4 million in Q3 2025, from $35.5 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $73.2 million in Q4 2021 to a low of -$6.4 million in Q3 2025.
- A 5-year average of $13.2 million and a median of $167606.0 in 2021 frame the typical range for Consolidated Net Income.
- The widest YoY moves for Consolidated Net Income: up 1873.05% in 2025, down 573.67% in 2025.
- Tracing SIGA's Consolidated Net Income over 5 years: stood at $73.2 million in 2021, then tumbled by 106.34% to -$4.6 million in 2022, then jumped by 1553.97% to $67.5 million in 2023, then tumbled by 32.16% to $45.8 million in 2024, then sank by 113.91% to -$6.4 million in 2025.
- The last three Consolidated Net Income figures came in at -$6.4 million (Q3 2025), $35.5 million (Q2 2025), and -$370415.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Siga Technologies | 213.74 Mn | 58.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | 35.47 Mn |
| Mar 31, 2025 | -370,415.00 |
| Dec 31, 2024 | 45.76 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 10.28 Mn |
| Dec 31, 2023 | 67.46 Mn |
| Sep 30, 2023 | -393,066.00 |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -917,677.00 |
| Dec 31, 2022 | -4.64 Mn |
| Sep 30, 2022 | 33.03 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | -361,049.00 |
| Dec 31, 2021 | 73.21 Mn |
| Sep 30, 2021 | -3.08 Mn |
| Jun 30, 2021 | 167,606.00 |
| Mar 31, 2021 | -812,105.00 |
| Dec 31, 2020 | 20.18 Mn |